250 likes | 266 Views
This case study discusses a middle-aged woman with symptoms of orbital inflammation, including tearing, crusty discharge, photophobia, and diplopia. Imaging revealed a mass with bone erosion and extension into the paranasal sinuses. Biopsies confirmed idiopathic orbital inflammation. Treatment options and the potential for bone involvement are addressed.
E N D
Idiopathic Orbital Inflammation (Inflammatory Orbital Pseudotumor) with Bone Erosion and Extension into the Paranasal Sinuses Alan D. Proia, M.D., Ph.D. Eastern Ophthalmic Pathology Society September 13-15, 2018
Clinical History • Woman in middle 30s with four month history of gradually worsening: • Tearing, crusty discharge, itching, and photophobia in her right eye • Difficulty focusing and eye strain after closing and then reopening her eyes • Diplopia • Pain in right eye during up, down, left, and right gaze • Protrusion of right eye • One month history of nausea when looking at objects close to her face
Examination • Proptosis O.D. • Exophthalmometry: 23 mm O.D. and 20 mm O.S. • Intraocular pressure 23 mmHg O.D. and 19 mmHg O.S. • Full extraocular movements but pain in right eye during left, right, up, and down movement
Computed Tomography • 2.8 x 1.9 x 3.2 cm mass involving the intraconal and extraconal nasal right orbit and extending to the orbital apex • Anterior displacement of the globe • Mass abutting the globe with loss of fat margin; effacement of the medial rectus muscle, portions of the fat plane, and the superior oblique muscle • Erosion of the mass through the orbital floor into the superior maxillary sinus and into the ethmoid sinus through the lamina papyracea
Surgery and Follow-up • Anterior orbitotomy with biopsy • 1.0 x 0.9 x 0.3 cm aggregate of tissue • Dense fibrous connective tissue with numerous lymphocytes and macrophages; rare cells expressing cytokeratins • One month later – anterior orbitotomy with biopsy of orbit and right ethmoid and maxillary sinuses • Diagnosis: Idiopathic orbital inflammation/idiopathic inflammatory pseudotumor
CD3 CD20 CD138 Lambda Kappa
IgG4 IgG
Idiopathic Orbital Inflammation • Enlarged structure or mass in the orbit that is of unknown cause and is manifest histologically by nonspecific inflammation with varying degrees of fibrosis • Other names: orbital pseudotumor, idiopathic orbital pseudotumor, inflammatory orbital pseudotumor, idiopathic orbital inflammatory syndrome, non-specific orbital inflammation
Idiopathic Orbital Inflammation • Incidence • 11% of lesions at Wills Eye Hospital Philadelphia, PA • 8.5% at Erasmus University Medical Center, Rotterdam, Netherlands • 5.2% at The University of Texas M.D. Anderson Cancer Center, Houston, TX • Classified by anatomic distribution • Mombaerts: dacryoadenitis, myositis, diffuse (several structures involved), or perineuritis
Idiopathic Orbital Inflammation • All age groups • Slight predominance in male gender • Most common symptoms and signs • Pain, diplopia, decreased vision, periorbital swelling, proptosis, restricted ocular motility • Histology • Nonspecific chronic inflammatory infiltrate of lymphocytes, plasma cells, histiocytes, eosinophils with degranulation, sometimes neutrophils
Idiopathic Orbital Inflammation • Histology, continued • Eosinophils may be prominent in children • Lymphoid follicles with germinal centers may be present, most common in chronic stage of disease • Degree of fibrosis is variable • T-lymphocytes predominate over B-lymphocytes • Polyclonal • Variants: Granulomatous IOI and idiopathic sclerosing orbital inflammation
Idiopathic Orbital Inflammation • Extraorbital extension • Bone erosion: 16 prior reports • Predominantly in diffuse IOI • Dacryoadenitis and myositis more common in patients without bone erosion • Through fissures and foramina without eroding through bone: 32 reported cases • Clifton and coworkers found extraorbital extension in CT scans of 8/90 (9%) of patients with biopsy confirmed IOI • Predominantly in diffuse IOI
Extraorbital Extension • Conclusion from review of the literature • Not possible to predict a priori which patient with diffuse IOI will exhibit bone erosion • Treatment similar to IOI without extension • Corticosteroids • Radiotherapy, immunosuppressive drugs, and/or surgical debulking in non-responsive IOI
Inflammatory Osteolysis From: G Mbalaviele, et al., Inflammatory osteolysis: a conspiracy against bone, J Clin Invest 127:2030-2039, 2017 Green = pro-osteoclast factors and red = anti-osteoclast factors